Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

Taekyu Lim; Jeeyun Lee; Duk Joo Lee; Ha Yeon Lee; Boram Han; Kyung Kee Baek; Hee Kyung Ahn; Su Jin Lee; Se Hoon Park; Joon Oh Park

首页> 外文期刊>Cancer Chemotherapy and Pharmacology >Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

【24h】

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

机译：卡培他滨联合依维莫司（RAD001）在先前治疗过的转移性胃癌患者中进行的I期临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose Everolimus is a novel inhibitor of the mammalian target of rapamycin pathway, which is aberrantly activated in cancer cell. We conducted a phase I study of capecitabine plus everolimus (RAD001) in refractory gastric cancer patients.

机译：目的Everolimus是雷帕霉素途径的哺乳动物靶标的新型抑制剂，雷帕霉素途径在癌细胞中异常激活。我们对难治性胃癌患者进行了卡培他滨联合依维莫司（RAD001）的I期研究。

著录项

来源
《Cancer Chemotherapy and Pharmacology》 |2011年第1期|p.255-262|共8页
作者
Taekyu Lim; Jeeyun Lee; Duk Joo Lee; Ha Yeon Lee; Boram Han; Kyung Kee Baek; Hee Kyung Ahn; Su Jin Lee; Se Hoon Park; Joon Oh Park;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-18 01:47:29

相似文献

外文文献
中文文献
专利

1. Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. [J] . Lim T, Lee J, Lee DJ, Cancer chemotherapy and pharmacology. . 2011,第1期

机译：卡培他滨联合依维莫司（RAD001）在先前治疗过的转移性胃癌患者中进行的I期临床试验。
2. Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients [J] . LeeJ., LeeS.J., ParkS.H., Investigational new drugs. . 2013,第6期

机译：卡培他滨和依维莫司（RAD001）联合治疗难治性胃癌患者的II期试验
3. 5021 Everolimus (RAD001) in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab: a multicenter phase I clinical trial [J] . S.Hurvitz, R.ORegan, M.Campone, European Journal of Cancer Supplements . 2009,第2期

机译：5021依维莫司（RAD001）与每周紫杉醇和曲妥珠单抗联合治疗对先前对曲妥珠单抗有耐药性的HER-2过表达转移性乳腺癌（MBC）的患者（pts）：一项多中心I期临床试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Clinical and Economic Outcomes for Gastric Cancer Patients Treated with Gastrectomy at Centres with and without Cancer Surgery Designation in Ontario [D] . Jeong, Yunni . 2019

机译：安大略省患有癌症手术指定胃癌治疗胃癌患者的胃癌患者的临床和经济结果
6. Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer [O] . Taekyu Lim, Jeeyun Lee, Duk Joo Lee, -1

机译：卡培他滨联合依维莫司（RAD001）在先前治疗过的转移性胃癌患者中进行的I期临床试验
7. Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer [O] . Taekyu Lim, Jeeyun Lee, Duk Joo Lee, 2011

机译：卡培他滨联合依维莫司（RAD001）在先前治疗过的转移性胃癌患者中进行的I期临床试验

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

摘要

著录项

相似文献

相关主题

期刊订阅